يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Hossain, A S Mukarram"', وقت الاستعلام: 0.33s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK, Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK

    Relation: https://dx.doi.org/10.1038/s41467-024-47547-3; Hynds RE, Huebner A, Pearce DR, Hil MS, Akarca AU, Moore DA, et al. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nature communications. 2024 MAY 31;15(1). PubMed PMID: WOS:001236598600008. English.; http://hdl.handle.net/10541/627031; Nature Communications

  2. 2
    Academic Journal

    المساهمون: Nucleic Acid Biomarker Team, Cancer Research UK National Biomarker Centre, The University of Manchester, Manchester, UK. Division of Cancer Sciences, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK. Bioinformatics and Biostatistics Team, Cancer Research UK National Biomarker Centre, The University of Manchester, Manchester, UK. Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.

    Relation: https://dx.doi.org/10.1038/s41467-024-47195-7; Conway AM, Pearce SP, Clipson A, Hill SM, Chemi F, Slane-Tan D, et al. A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nature communications. 2024 Apr 17;15(1):3292. PubMed PMID: 38632274. Pubmed Central PMCID: PMC11024142 Bioven, Amgen, Carrick Therapeutics, Merck AG, Taiho Oncology, GSK, Bayer, Boehringer Ingelheim, Roche, BMS, Novartis, Celgene, Epigene Therapeutics Inc, Angle PLC, Menarini, Clearbridge Biomedics, Thermo Fisher Scientific, Neomed Therapeutics. C.D. has received/receives honoraria/consultancy fees from Biocartis, Merck, AstraZeneca and GRAIL. Outside of the scope of work, research funding/educational research grants has been received from by the Experimental Cancer Medicine Team (PI: Cook) from AstraZeneca, Bayer, Pfizer, Orion, Taiho, Oncology, Roche, Starpharma, Eisai, RedX, UCB, Boeringher, Merck, Stemline Tarveda and Avacta. M.G.K has received consultancy/advisory board fees from Bayer, Guaradant Health, Janssen, Roche, Seattle Genetics; speakers fees from Janssen, Roche; research funding from Novartis, Roche and travel expenses from Immutep, Janseen and Roche. The remaining authors declare no competing interests. Epub 2024/04/18. eng.; http://hdl.handle.net/10541/627005; Nature Communications

  3. 3
    Academic Journal